Advertisement

BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 600x60px
Document › Details

Caprotec Bioanalytics GmbH. (1/26/10). "Press Release: Caprotec Bioanalytics Announces Commercial Launch of Three New caproKits for Applications in Proteomics and Drug Development". Berlin & Burlington, MA.

Organisations Organisation Caprotec Bioanalytics GmbH
  Organisation 2 Caprotec Inc.
  Group Caprotec (Group)
Products Product Marimastat caproKit
  Product 2 CCMS technology (Capture Compound Mass Spectrometry)
Persons Person Köster, Hubert (Caprotec 200805–201009 Managing Director + Univ Hamburg + Sequenom founder + CEO)
  Person 2 Jurinke, Christian (Stratec 201110 Marketing Manager at Stratec Molecular before Caprotec before Sequenom)
     


caprotec bioanalytics GmbH announced today the commercial launch of three new caproKits(TM), enabling the discovery, identification and characterization of proteins belonging to the groups of metallo-proteases, histon-deacetylases and GDP/GTP binding
proteins.

The three new kits are the Marimastat caproKit, SAHA caproKit and GDP caproKit,
respectively and increase the number of commercially available caproKits to a total
of seven.

The company’s caproKits are based on the proprietary Capture Compound Mass
Spectrometry (CCMS) technology, a novel and direct way to investigate small
molecule - protein interactions resulting in a significant functional reduction of
proteome complexity. Capture Compounds(TM) enable direct isolation and
identification of proteins including membrane proteins out of complex biological
samples.

The new and existing caproKits target different areas of research ranging from
signal transduction (cAMP, cGMP, Stauro and the new GDP caproKit) to epigenetics
(SAH and the new SAHA caproKit), and proteases (Marimastat caproKit). Additional
caproKits for applications in these and other research areas are under development
and will be released in the coming months.

“Our new caproKits are innovative and effective tools for researchers in the field of
proteomics needing a solution for targeted reduction of sample complexity,” stated
Dr. Hubert Köster, CEO of caprotec bioanalytics. “Our most recent scientific
publications in Molecular and Cellular Proteomics and Toxicological Sciences provide
powerful testimonials for the capabilities of our CCMS technology.“


About caprotec bioanalytics GmbH

caprotec bioanalytics is headquartered in Berlin, Germany with a US subsidiary in
Burlington, MA. The company focuses on the commercialization of its proprietary
Capture Compound Mass Spectrometry (CCMS) technology. The core of the CCMS
technology consists of small, tri-functional molecules called Capture
Compounds(TM). They enable a targeted isolation of proteins directly from complex
biological samples. After isolation the captured proteins are identified and
characterized by mass spectrometry or gel electrophoresis and Western blotting.
Providing a state-of-the-art platform for the isolation and analysis of proteins from
complex mixtures, the CCMS technology has enormous potential in proteomics, drug
development and the development of biomarkers. The technology is protected by a
broad patent portfolio.

Publications:

Luo, Y. et al. (2009), Mol. Cell. Proteomics 8, pp. 2843-2856: The cAMP capture
compound mass spectrometry as a novel tool for targeting cAMP-binding proteins:
from protein kinase A to potassium/sodium hyperpolarization-activated cyclic
nucleotide-gated channels.

Fischer, J.J. et al. (2009), Toxicol. Sci., in press, advanced online publication
available: Capture Compound Mass Spectrometry (CCMS) Sheds Light on the
Molecular Mechanisms of Liver Toxicity of two Parkinson Drugs.

For further information please contact:

Dr. Hubert Köster, CEO, caprotec GmbH
Phone: +49 (0)30-6392-3990

or

Dr. Christian Jurinke, President, caprotec Inc.
Phone: (781) 685-4992
info@caprotec.com
www.caprotec.com

   
Record changed: 2016-03-19

Advertisement

Picture AB Sciex Berliner LCMSMS Symposium 2017 Middle 600x60px

More documents for Caprotec Bioanalytics GmbH


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 120x180px Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 120x180px Picture AB Sciex Berliner LCMSMS Symposium 2017 Right 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px